The Pharmaceutical Research and Manufacturers of America has once again criticized FDA for the kind of research it is conducting on Rx drug advertisements, this time citing the number of projects the agency has initiated in the last five years.
In
PhRMA Criticizes 'Exponential Pace' Of FDA Rx Drug Advertising Studies
US FDA responds to comments on proposed study of product disclosures and study of amount and location of risk information.
